Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment. (2022)
Attributed to:
Aetiology and Mechanisms of Diabetes and Related Metabolic Disorders of Later Life
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.phrs.2022.106237
PubMed Identifier: 35487405
Publication URI: http://europepmc.org/abstract/MED/35487405
Type: Journal Article/Review
Volume: 180
Parent Publication: Pharmacological research
ISSN: 1043-6618